OpenVSafe by OpenVAERS
Search V-safe

Q39-24452-19632

2 vaccinations 3 coded responses 14 check-ins 3 free-text entries 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
933 / CA
Registered
2022-01-22
Relationship
Child or adolescent in my care
Guardian
Q5C-14217-49923
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-01-22
    Registered in v-safe
  2. 2022-01-26
    Dose 1 — Pfizer-BioNTech
  3. 2022-01-26
    Health check-in — day 0, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  4. 2022-01-27
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2022-01-28
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  6. 2022-01-29
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2022-01-30
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  8. 2022-02-02
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  9. 2022-02-10
    Survey response — day 14, dose 1, dependent
    MedDRA: Headache, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school
    Free text: Runny nose, congestion, headache.
    MedDRA releases: 2024-11 · check-in free text available
  10. 2022-02-16
    Dose 2 — Pfizer-BioNTech
  11. 2022-02-17
    Survey response — days 1–6 daily, dose 2, dependent
    MedDRA: Discharge, Nasal congestion, Productive cough — Feeling: Fair · Site: Pain
    Free text: Nasal congestion and drainage. Phlegmy, productive cough.
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-02-21
    Survey response — days 1–6 daily, dose 2, dependent
    MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Site: Pain
    Free text: Congestion & nasal drainage
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-02-22
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  14. 2022-03-09
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  15. 2022-03-16
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  16. 2022-03-23
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  17. 2022-03-30
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-01-26Pfizer-BioNTech No
22022-02-16Pfizer-BioNTech No

Free text

Release 11 — day 14, dose 1, dependent

2022-02-10

Symptoms: Runny nose, congestion, headache.

Release 11 — days 1–6 daily, dose 2, dependent

2022-02-17

Systemic reaction (other): Nasal congestion and drainage. Phlegmy, productive cough.

2022-02-21

Systemic reaction (other): Congestion & nasal drainage

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SRODischarge · · ✓
SRONasal congestion · · ✓
SROProductive cough · · ✓
SRORespiratory tract congestion · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release